|
www.life123.com/question/Breast-Cancer-Radiation-Therap...
www.life123.com/question/Breast-Cancer-Radiation-Therapy
|
The majority of breast and uterine cancers are estrogen receptor positive, indicating that these cancers may be stimulated or maintained by estrogen. ... Side Effects of Radiation Therapy
|
|
www.life123.com/question/Breast-Cancer-and-Radiation-Th...
www.life123.com/question/Breast-Cancer-and-Radiation-Therapy
|
The majority of breast and uterine cancers are estrogen receptor positive, indicating that these cancers may be stimulated or maintained by estrogen. ... Side Effects of Radiation Therapy
|
|
www.ncbi.nlm.nih.gov/pubmed/16136271
|
Interaction between estrogen receptor alpha, ionizing radiation and (anti-) estrogens in breast cancer cells. Toillon RA, Magné N, Laïos I, Lacroix M, Duvillier H, ...
|
|
www.ncbi.nlm.nih.gov/pubmed/20051651
|
Jan 6, 2010 ... Involvement of substance P and the neurokinin-1 receptor in radiation-induced hair loss in mice. Yamamoto K, Kureyama N, Asano K, Ikeda T, ...
|
|
www.ncbi.nlm.nih.gov/pubmed/17656330
|
May 25, 2007 ... Role of the angiotensin II type-2 receptor in radiation nephropathy. Cohen EP, Fish BL, Sharma M, Li XA, Moulder JE. Department of Medicine ...
|
|
|
|
www.transonc.com/pdf/manuscript/v05i01/neo11265.pdf
|
the role of new therapies leading to block the receptor to enhance the efficacy of radiation. Translational Oncology (2012) 5, 1–9. Insulin-like Growth Factor 1 ...
|
|
www.jbc.org/content/259/20/12431.full.pdf
|
Identification of the Prostacyclin Receptor by Radiation Inactivation*. (Received for publication, February 13, 1984). Philippa J. Leigh, William A. Cramp$, and ...
|
|
www.sciencemag.org/content/320/5873/226
|
Apr 11, 2008 ... The toxicity of ionizing radiation is associated with massive apoptosis ... to Toll- like receptor 5 (TLR5) and activates nuclear factor–κB signaling.
|
|
cancerres.aacrjournals.org/content/early/2011/09/07/000...
cancerres.aacrjournals.org/content/early/2011/09/07/0008-5472.CAN-11-1646
|
Sep 8, 2011 ... Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation. Nicholas C.K. Valerie1,; Eli V. Casarez2,; John O ...
|
